Current drug use patterns and HIV and HCV prevalence among people who inject drugs in suburban areas of Malaysia.  Pang J, Danaee M, Balasingam Kasinather V, Des Jarlais D, Kamarulzaman A, Mohd Salleh NA.  J Int AIDS Soc. 2025 May;28(5)…

Seroprevalence of Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Among People Who Use Drugs in Turkey.  Asan A, Turan C, Senormanci O, Sayar MS, Metin S, Hakyemez IN.  Open Forum Infect Dis. 2025 Mar 13;12(4):ofaf…

Engagement in hepatitis C virus cascade of care and factors associated with testing among people who inject drugs in Iran.  Khezri M, Tavakoli F, Mehmandoost S, Sharafi H, Zamani O, Bazrafshani MS, Nasiri N, Mirzaei H, Moameri H, Haghdoost AA…

Direct-acting antivirals (DAA) positively affect depression and cognitive function in patients with chronic hepatitis C.  Pawłowski T, Radkowski M, Perlejewski K, Szymańska B, Berak H, Horban A, et al. (2025)  PLoS ONE 20(4): e0320221. d…

Does HCV treatment completion affect the neurocognitive outcomes in patients on opioid agonist maintenance treatment: A secondary analysis. Ghosh A, Verma A, De A, Premkumar M, Duseja A, Nehra R, Basu D. Indian J Psychiatry. 2025 Feb;67(2):260-266…

Teilziele im Kampf gegen HIV und Hepatitis verfehlt Stockholm – Hepatitis, HIV, Tuberkulose (TB) und sexuell übertragbare Infektionen wie Syphilis und Gonorrhoe stellen weiterhin große Herausforderungen für die Gesundheitssysteme in Europa dar. Das…